
Overview
Centrum Badań Medycznych Brand Med is engaged in a project funded by European funds aimed at acquiring equipment to expand its research and development capabilities. The focus of this project is on developing innovative methods for screening, diagnosing, and treating ophthalmic conditions, specifically glaucoma and diabetic retinopathy.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $1,577 | |
| Profit allocation | No decision | |
| Parent company | osoba fizyczna |
Filing timeliness
Financial statements were filed on time, on average 78 days early.
- 202524/06/2026
- 202428/03/2025
- 202327/03/2024
- 202231/03/2023
- 202129/06/2022
- 202029/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
- Hospital activities (86.10.Z) Primary
Authorized Representatives
Manner of representation
Each member of the management board is authorised to sign and make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jerzy Zygmunt Szaflik age 82 | 4,100 | $55,375.47 | 100% |
Beneficial owners
No beneficial owners recorded for the company Centrum Badań Medycznych Brand Med.
Bank accounts
Registered as a VAT taxpayer on 2019-09-21.
69 1020 4476 0000 8302 0381 6345
32 1020 4476 0000 8502 0389 3252
Debt
No entries in the National Debtors Register (KRZ).
Public aid
6 public aid cases recorded, with a total value of $71,990.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $423$423 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $423$423 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 13, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $9,231$9,231 | Polski Fundusz Rozwoju S.A. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-05-01 | Expansion of research and development facilities to develop proprietary innovative methods for screening, diagnosis and treatment of glaucoma and diabetic retinopathy. | $61,421$61,421 | Regional Operational Programme for the Mazowieckie Voivodeship for 2014-2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aurismed S.A. | $477,685.18 | aurismed.pl | ||
| Arkmedic sp. z o.o. | $462,335.60 | arkmedic.pl | ||
| Klinika Medyczna Allmedica sp. z o.o. | $331,953.35 | allmedica.pl | ||
| Care Access Polska sp. z o.o. | $305,248.06 | careaccess.pl | ||
| Holispace sp. z o.o. | $207,485.21 | holispace.com | ||
| Optimum Medica sp. z o.o. | $180,525.61 | carolina.pl | ||
| Praskie Centrum Medyczne N.Z.O.Z. sp. z o.o. | $131,265.44 | praskiecentrummedyczne.pl | ||
| Onkomedica sp. z o.o. | $69,344.55 | onkomedica.pl | ||
| Inspiromed sp. z o.o. | $67,417.10 | inspiromed.pl | ||
| DR Szczyt Chirurgia Plastyczna sp. z o.o. | $62,029.93 | drszczyt.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-11-20 | Share capital increase (5,000.00 PLN → 205,000.00 PLN) | |
| 2017-10-09 | Entered in the register |
FAQ
Last updated: 2026-10-07